Company Quick10K Filing
Quick10K
VTV Therapeutics
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
8-K 2019-11-26 Sale of Shares
8-K 2019-11-25 Officers
8-K 2019-11-12 Sale of Shares
8-K 2019-10-30 Earnings, Exhibits
8-K 2019-10-24 Sale of Shares
8-K 2019-09-26 Enter Agreement, Off-BS Arrangement, Sale of Shares
8-K 2019-09-18 Sale of Shares
8-K 2019-09-11 Officers
8-K 2019-09-11 Sale of Shares
8-K 2019-09-04 Sale of Shares
8-K 2019-08-06 Sale of Shares
8-K 2019-07-31 Earnings, Exhibits
8-K 2019-07-09 Sale of Shares
8-K 2019-06-25 Sale of Shares
8-K 2019-05-15 Sale of Shares
8-K 2019-04-29 Earnings, Shareholder Vote, Exhibits
8-K 2019-03-18 Enter Agreement, Off-BS Arrangement, Sale of Shares, Other Events, Exhibits
8-K 2019-03-07 Officers, Exhibits
8-K 2019-02-28 Sale of Shares
8-K 2019-02-27 Earnings, Exhibits
8-K 2019-02-19 Regulation FD, Exhibits
8-K 2019-02-14 Sale of Shares
8-K 2019-01-29 Sale of Shares
8-K 2019-01-16 Sale of Shares
8-K 2018-12-27 Sale of Shares
8-K 2018-12-11 Enter Agreement, Off-BS Arrangement, Sale of Shares, Other Events
8-K 2018-11-29 Sale of Shares
8-K 2018-11-08 Earnings, Exhibits
8-K 2018-10-29 Exhibits
8-K 2018-09-28 Officers
8-K 2018-09-27 Sale of Shares
8-K 2018-09-17 Other Events
8-K 2018-09-06 Sale of Shares
8-K 2018-08-10 Sale of Shares
8-K 2018-08-03 Earnings, Exhibits
8-K 2018-07-30 Enter Agreement, Off-BS Arrangement, Sale of Shares
8-K 2018-07-06 Sale of Shares
8-K 2018-06-18 Sale of Shares
8-K 2018-06-12 Regulation FD, Exhibits
8-K 2018-05-31 Enter Agreement
8-K 2018-05-24 Sale of Shares
8-K 2018-04-30 Shareholder Vote
8-K 2018-04-23 Officers
8-K 2018-04-09 Regulation FD, Exhibits
8-K 2018-02-27 Earnings, Exhibits

VTV Therapeutics Financials

-

VTVT Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comparables ($'000 Annual) Ticker Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Advaxis ADXS 5,775 56,133 6,864 22,012 0 1,812 3,429 -35,980
Tonix Pharmaceuticals Holding TNXP 8,683 15,008 2,186 0 0 -23,639 -23,595 -3,567
Delmar Pharmaceuticals DMPI 10 4,037 2,070 0 0 8,048 8,048 -3,709
Diffusion Pharmaceuticals DFFN 1,924 18,929 2,752 0 0 -17,534 -17,962 -6,448
Phibro Animal Health PAHC 0 726,671 510,656 624,112 264,624 54,713 109,193 173,717
OHR Pharmaceutical OHRP 10,129 8,693 752 0 0 -9,529 -8,750 8,704
Therapix Biosciences TRPX 0 4,560 -0 0 0 0 0 -1,518
AstraZeneca AZN -0 60,651,000 46,607,000 0 0 0 0 -893,000
Kiniksa Pharmaceuticals KNSA -0 308,137 32,940 0 0 -169,998 -170,154 -287,447
Bioblast Pharma ORPN 39,270 11,034 1,328 0 0 -3,073 -3,073 29,534
Zomedica Pharmaceuticals ZOM -0 9,479 1,797 0 0 -24,413 -24,124 -5,822
Trillium Therapeutics TRIL -0 55,459 13,858 0 0 0 0 -0
Nabriva Therapeutics NBRV 678,758 83,645 40,240 3,486 0 -125,573 -123,455 629,164
Grifols GRFS -0 12,477,046 7,780,442 0 0 0 0 -592,178
VTV Therapeutics VTVT -0 9,072 21,914 10,646 0 -6,924 -4,119 5,935
Immtech Pharmaceuticals IMMP
Novo Nordisk NVO
Affimed AFMD -0 116,174 -0 0 0 0 0 -0
Zealand Pharma ZEAL
Intec Pharma NTEC -0 46,860 11,751 0 0 -20,665 -20,593 -20,796

Balance Sheet ($'000)2015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash2,39797,01088,00375,50163,84151,05851,50545,15032,51320,48814,4209,0353,6636,2664,1837,4593,962
Accounts Receivable00692060000008,0002102,27001,822
Inventory
PP&E3,51666911,71254556149310,8984263743109,3992412021778,5016254
Assets18,966100,19591,53279,55966,78354,71554,49548,32935,77924,05527,91714,72911,22611,0898,55910,7369,072
Accounts Payable3,2623,0602,2692,899
Long-Term Debt
Liabilities99,9116,1297,9718,91110,05310,80822,92530,13930,04429,71647,52443,12043,41035,15528,93023,36521,914
Stockholders' Equity-94,185-77,970-63,022-79,520-111,240-90,945-123,469-106,410-136,303-151,047-148,788-71,597-43,978-82,853-57,735-49,902
Income Statement ($'000)2015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue11013322637618238383013152332,0642,4733,3754,5229211,828
Cost of Revenue
Gross Profit
R&D5,1466,57411,14112,07710,63610,9609,6238,98910,0688,9438,5942,6982,8002,8224,228
SG&A
Tax00000008000200000100
Net Income-2,179-4,103-3,170-3,852-4,457-3,993-4,050-4,220-3,963-3,650-4,311-2,952-3,072-796-1,091-2,155-2,882
Cash Flow ($'000)2015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-6,260-5,869-5,450-5,497
Cash Investing-50
Cash Financing8,8683,7868,7262,000